Case Studies

Craig I. Coleman, PharmD, and Lanting Fuh, PharmD Candidate
Published Online: Tuesday, July 10, 2012
ZR is a 32-year-old woman who presents to your pharmacy with complaints of moderate nausea and vomiting. She is 10 weeks pregnant and states she has already tried her doctor’s advice regarding dietary and lifestyle modifications (ie, avoiding spicy and fatty foods; avoiding aggravating environmental triggers; eating small, frequent meals; and taking frequent breaks) with minimal improvement. She would now like to try an OTC medication that “won’t harm my baby.” She has no known drug allergies.
As the pharmacist, what would you recommend?

JF, a 57-year-old woman recently diagnosed with a Helicobacter pylori infection, presents to the pharmacy counter to pick up her prescriptions for clarithromycin and metronidazole. In her hand, JF holds a box of omeprazole (as advised by her doctor to round out her 3-drug H pylori regimen) and a bottle of Nyquil that she states is to “help me sleep at night.” Other than penicillin, she has no known allergies.
What counseling points should the pharmacist have for JF?

Win an iPad! Submit your recommendations for how to handle these cases at and you will be entered into a drawing to win an iPad! Must register to win.

Dr. Coleman is associate professor of pharmacy practice and director of the pharmacoeconomics and outcomes studies group at the University of Connecticut School of Pharmacy. Ms. Fuh is a PharmD candidate from the University of Connecticut School of Pharmacy.

Latest Articles
The FDA has approved Boehringer Ingelheim’s oral direct thrombin inhibitor dabigatran etexilate mesylate (Pradaxa) for the prophylaxis of deep vein thrombosis and pulmonary embolism in patients who have had hip replacement surgery.
As a result of implementation difficulties, the FDA announced that it will extend the pharmacy certification deadline for the clozapine risk evaluation and mitigation strategy program.
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Latest Issues